ClinicalTrials.govpublic full text
A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanil
early gastric cancer patients who were scheduled for endoscopic submucosal dissection, endoscopic submucosal dissection, propofol, remifentanil, dexmedetomidine, efficacy, safeness, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 980974
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.